Blueprint Medicines Corpo... (BPMC)
NASDAQ: BPMC
· Real-Time Price · USD
129.46
0.18 (0.14%)
At close: Jul 17, 2025, 3:59 PM
Blueprint Medicines Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 496K | -49.96M | -56.27M | -49.99M | 89.14M | -110.92M | -133.71M | -132.79M | -129.56M | -158.65M | -133.16M | -159.71M | -106M | -318.69M | -117.24M | -108.44M | -99.71M |
Depreciation & Amortization | 1.13M | 4M | 3.86M | 3.62M | 4.81M | 1.53M | 2.87M | 3.58M | 3.68M | 7.02M | 1.62M | 1.47M | 1.63M | 1.66M | 1.62M | 1.59M | 1.61M |
Stock-Based Compensation | 29.06M | 28.38M | 28.28M | 28.02M | 24.23M | 22.59M | 23.07M | 23.82M | 23.2M | 26.12M | 24.11M | 25.35M | 23.4M | 22.68M | 23.96M | 24.31M | 20.68M |
Other Working Capital | n/a | -1.99M | -3.58M | 3.03M | -28.87M | 13.64M | 5.89M | -8.15M | -29.36M | -10.27M | 1.21M | 19.11M | -50.65M | 25.01M | -14.3M | 8.59M | -16.5M |
Other Non-Cash Items | -85.16M | -1.65M | -4.97M | -2.91M | -128.31M | 26.36M | 11.84M | 3M | 6.14M | 10.41M | -16.77M | 1.81M | 2.85M | 262.3M | 2.92M | 2.37M | 2.06M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -28.89M | -11.53M | n/a | n/a | n/a | n/a | n/a | n/a | 1.36M | n/a | n/a | n/a |
Change in Working Capital | n/a | -10.14M | 15.46M | -26.81M | -43.2M | 10.4M | 2.97M | -28.08M | -26.42M | -6.31M | -5.69M | 12.83M | -54.6M | 16.57M | -6.85M | 17.01M | -50.41M |
Operating Cash Flow | -54.48M | -29.36M | -13.64M | -48.07M | -101.51M | -78.93M | -104.48M | -130.47M | -122.96M | -121.41M | -129.89M | -118.26M | -132.73M | -14.11M | -95.6M | -63.16M | -125.78M |
Capital Expenditures | -1.83M | -932K | -25K | -2.57M | -1.1M | -4.67M | -6.25M | -2.55M | -2.58M | -1.48M | -3.73M | -2.56M | -1.15M | -259.41M | -996K | -662K | -173K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | -83.44M | 3.33M | -34.62M | -175.38M | n/a | n/a | n/a | n/a | -35.38M | n/a | n/a | n/a |
Purchase of Investments | -283.33M | -209.77M | -201.02M | -355.47M | -200.16M | -117.66M | -240.94M | -274.89M | -132.88M | -231.05M | -218.72M | n/a | -39.94M | -140.54M | -132.26M | -299.56M | -83.08M |
Sales Maturities Of Investments | 350.24M | 244.41M | 231M | 169.75M | 278.4M | 201.1M | 237.6M | 309.51M | 308.25M | 179.25M | 90.5M | 79.62M | n/a | 53M | 237.33M | 185.05M | 215.45M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 78.23M | 83.44M | -3.33M | 34.62M | 175.38M | -1K | -289K | 79.62M | -39.94M | 35.38M | 105.07M | -114.51M | 132.37M |
Investing Cash Flow | 65.08M | 33.71M | 29.95M | -188.29M | 77.13M | 78.77M | -9.59M | 32.07M | 172.79M | -53.28M | -132.24M | 77.07M | -41.09M | -346.95M | 104.07M | -115.18M | 132.2M |
Debt Repayment | n/a | 541K | n/a | 146.8M | -369K | -35K | 97.97M | n/a | n/a | -11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 9.19M | 9.22M | 18.38M | 31.21M | 18.4M | 15.56M | 431K | 5.3M | n/a | 2.5M | 380.56M | 177.5M | 1.26M | 17.93M | 10.92M | 14.85M | 7.01M |
Financial Cash Flow | 9.19M | 9.76M | 18.38M | 178.01M | 66.96M | 15.53M | 98.4M | 5.3M | n/a | 2.49M | 380.56M | 177.5M | 1.26M | 17.93M | 10.92M | 14.85M | 7.01M |
Net Cash Flow | 20.45M | 12.78M | 46.09M | -58.55M | 42.04M | 15.31M | -16.21M | -93.05M | 50.03M | -171.72M | 118.05M | 136.2M | -172.75M | -343.64M | 19.28M | -163.65M | 13.33M |
Free Cash Flow | -56.31M | -30.3M | -13.66M | -50.64M | -102.62M | -83.6M | -110.73M | -133.03M | -125.55M | -122.89M | -133.62M | -120.81M | -133.88M | -273.52M | -96.59M | -63.83M | -125.95M |